Publications

Publications

Filter Results: (1,248) Arrow Down
Filter Results: (1,248) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 40 of 1,248 Results →
  • October 1992 (Revised September 1993)
  • Case

Nopane Advertising Strategy

By: David E. Bell
Nopane is a proprietary drug that sells in much of the United States. It faces substantial competition. The brand manager is undertaking an experiment to determine whether ad copy should be emotional-based or rational-based. The data and associated regression results... View Details
Keywords: Competition; Intellectual Property; Advertising; Health Care and Treatment; Brands and Branding; Product Marketing; Pharmaceutical Industry; United States
Related
  • February 1998 (Revised October 1998)
  • Background Note

Note on New Drug Development in the United States

By: Stefan H. Thomke and Ashok Nimgade
An overview of the new drug development process in the United States, using the migraine drug Imitrex as an illustrative example. View Details
Keywords: Product Development; Research and Development; Health; Pharmaceutical Industry; United States
Related
  • February 1996 (Revised April 2004)
  • Case

Eli Lilly and Company: Innovation in Diabetes Care

By: Clayton M. Christensen
Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the... View Details
Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry
Related
  • August 1995
  • Teaching Note

Eli Lilly and Company: The Flexible Facility Decision (1993) TN

By: Gary P. Pisano
Teaching Note for (9-694-074). View Details
Keywords: Pharmaceutical Industry
Related
  • February 1987 (Revised January 1989)
  • Case

SmithKline Consumer Products: The Contac Relaunch

In March 1986, a tamperer contaminated CONTAC Cold Capsules, SmithKline Consumer Product's most popular product. To relaunch CONTAC after withdrawing it from the market, the management team had to present a plan of action to the corporation board. They knew CONTAC's 25... View Details
Keywords: Safety; Crisis Management; Product Launch; Pharmaceutical Industry
Related
  • February 1974
  • Case

Listerine Lozenges

By: Stephen A. Greyser
Keywords: Advertising Campaigns; Pharmaceutical Industry
Related
  • February 1992 (Revised April 1995)
  • Case

Pfizer: Global Protection of Intellectual Property

By: Lynn S. Paine and Michael Santoro
Top officials at Pfizer are assessing their strategy for improving protection of Pfizer's patents around the world. The outcome of the Uruguay Round of the GATT negotiations is uncertain, and it is not clear whether an acceptable intellectual property protection... View Details
Keywords: Patents; Trade; Policy; Government and Politics; Business Strategy; Agreements and Arrangements; Alliances; Cross-Cultural and Cross-Border Issues; Pharmaceutical Industry; United States; Japan; Europe
Related
  • August 1990 (Revised March 1991)
  • Case

Eli Lilly and Co. (C): Japan

By: Michael Y. Yoshino
Describes the process of establishing an independent operation in Japan in the mid-1980s as a result of a decision to make a major investment in the market. Describes the challenges in setting up such an operation and focuses on the role of the country manager in... View Details
Keywords: Business Divisions; Business Startups; Decisions; Investment; Growth Management; Managerial Roles; Markets; Problems and Challenges; Pharmaceutical Industry; Japan
Related
  • April 1989 (Revised January 1994)
  • Case

Novo Industri

By: Michael E. Porter and Michael J. Enright
Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an... View Details
Keywords: Change; Global Strategy; Industry Structures; Alliances; Competitive Strategy; Health Disorders; Pharmaceutical Industry
Related
  • 23 Jun 2003
  • Research & Ideas

Historically Speaking: A Roundtable at HBS

States, Europe, and Japan, it was supposed to examine two sectors: first, the chemical and pharmaceutical industries, which helped bring about the Second Industrial Revolution between the 1880s and 1920s, and second, consumer electronics... View Details
Keywords: by Jim Aisner
  • Profile

Evan Rachlin

experienced as a medical student, business issues are an inescapable reality for any physician. While shadowing a pediatrician in private practice, he noticed the tension between the busy physician and a pharmaceutical representative... View Details
  • 01 Dec 2003
  • News

Alumni Luminaries Discuss Careers, Values with HBS Students

Internal Revenue Service. Senior advisor, The Carlyle Group. He upgraded technology and information systems and stressed customer service in a dramatic turnaround of the IRS. Daniel L. Vasella, M.D. (PMD 57, 1989), chairman and CEO of Novartis AG, the world’s... View Details
  • 01 Oct 2013
  • First Look

First Look: October 1

these issues, increase performance, and set a direction for the company, all while remaining true to the values of his family's business. Purchase this case: http://hbr.org/search/413086-PDF-ENG Harvard Business School Case 313-016 Shanghai View Details
Keywords: Sean Silverthorne
  • 17 Mar 2009
  • First Look

First Look: March 17, 2009

Agreements in Bio-Pharmaceuticals Authors:Juan Alcácer, John Cantwell, and Michelle Gittelman Publication:In Location of Biopharmaceutical Activity, edited by Iain M. Cockburn and Matthew J. Slaughter. NBER, forthcoming. Abstract As the value chain of the View Details
Keywords: Martha Lagace
  • Student-Profile

Byungyeon Kim

important Harvard’s worldwide research centers would be to his work. His second year research project involved a study of sales force compensation that resulted from a partnership with a Turkish pharmaceutical company made possible by an... View Details
  • 03 Nov 2016
  • News

17 Ventures Join the Pagliuca Harvard Life Lab

Institute/HMS Nix – HBS, SEAS, Blavatnik Fellow PathoVax – HMS Piper Therapeutics – College, HBS Riparian Pharmaceuticals – College, SEAS Suono Bio – HMS UnNamed – HMS UrSure Inc. – HKS Vaxess Technologies, Inc. HBS, SEAS, HKS, HLS... View Details
Keywords: Scientific Research and Development Services
  • Portrait Project

Mickey Millar

roach. Each incident left a stain on my spirit. While studying social welfare at HKS, I worked part-time so my pregnant sister wouldn't become homeless after she lost her job while on bed rest. During pharmaceutical case discussions at... View Details
  • Fast Answer

Patent search: Product-associated patents

face="Open Sans">  Check company website. Some companies may lists patents associated with their products on their websites.  For View Details
  • 01 Dec 2020
  • News

The Complete Package

school, she got a job in a hotel sales department and decided to defer her education. Two years later, Pfizer headhunted Chong. She didn’t know the number of chambers in the heart, she admitted during her interview with the pharmaceutical... View Details
Keywords: April White; entrepreneurship; sustainability; packaging; leadership; women; Manufacturing
  • 01 Mar 2009
  • News

A New Approach to Health-Care Reform

approach not just to insurance and reimbursement, but also to the places where medical services are delivered, the way we use technology, the way pharmaceuticals are developed, the way we educate medical professionals, and who performs... View Details
Keywords: Deborah Blagg; Health, Social Assistance